Thomas M. Luby

412 total citations
12 papers, 350 citations indexed

About

Thomas M. Luby is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Thomas M. Luby has authored 12 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Thomas M. Luby's work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Thomas M. Luby is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Thomas M. Luby collaborates with scholars based in United States and Japan. Thomas M. Luby's co-authors include Erik Selsing, Janet Stavnezer, Carol E. Schrader, Mary Lynne Hedley, Urban Ramstedt, Christine M. Barbon, Irene M. Min, G A Cole, Roman M. Chicz and Mark Matijevic and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Immunity.

In The Last Decade

Thomas M. Luby

12 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas M. Luby United States 10 216 136 65 50 25 12 350
Marjory Desmedt Belgium 7 227 1.1× 149 1.1× 57 0.9× 61 1.2× 13 0.5× 9 411
Olga P. Ryabinina United States 9 103 0.5× 242 1.8× 47 0.7× 44 0.9× 26 1.0× 12 396
Ruduan Wang United States 9 215 1.0× 134 1.0× 64 1.0× 25 0.5× 9 0.4× 14 351
Sebastián Cruz-Gómez United States 9 151 0.7× 122 0.9× 74 1.1× 26 0.5× 15 0.6× 16 340
Louise McNeill United Kingdom 8 356 1.6× 179 1.3× 56 0.9× 86 1.7× 11 0.4× 8 547
Céline Garcia France 9 136 0.6× 162 1.2× 53 0.8× 52 1.0× 11 0.4× 14 355
Jesper Kastrup Denmark 10 359 1.7× 252 1.9× 94 1.4× 26 0.5× 22 0.9× 14 595
Koon-Guan Lee Singapore 10 349 1.6× 206 1.5× 59 0.9× 51 1.0× 13 0.5× 10 546
Wan‐Ting Kan Australia 7 144 0.7× 76 0.6× 41 0.6× 65 1.3× 11 0.4× 7 347
Eun Gene Sun South Korea 14 108 0.5× 203 1.5× 99 1.5× 53 1.1× 35 1.4× 25 387

Countries citing papers authored by Thomas M. Luby

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Luby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Luby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Luby more than expected).

Fields of papers citing papers by Thomas M. Luby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Luby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Luby. The network helps show where Thomas M. Luby may publish in the future.

Co-authorship network of co-authors of Thomas M. Luby

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Luby. A scholar is included among the top collaborators of Thomas M. Luby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Luby. Thomas M. Luby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Barbon, Christine M., et al.. (2010). Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunization. Cellular Immunology. 262(2). 150–161. 34 indexed citations
3.
Barbon, Christine M., et al.. (2010). In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization. Vaccine. 28(50). 7852–7864. 14 indexed citations
4.
Luby, Thomas M.. (2008). Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine. Expert Review of Vaccines. 7(7). 995–1003. 12 indexed citations
5.
Alt, Jesse, et al.. (2008). AKR-501 Activates the Thrombopoietin Receptor through Interaction with the Transmembrane Domain. Blood. 112(11). 5391–5391. 6 indexed citations
7.
Yin, Peng, Thomas M. Luby, Hongmin Chen, et al.. (2003). Generation of expression constructs that secrete bioactive αMSH and their use in the treatment of experimental autoimmune encephalomyelitis. Gene Therapy. 10(4). 348–355. 26 indexed citations
8.
Min, Irene M., et al.. (2003). The Sμ Tandem Repeat Region Is Critical for Ig Isotype Switching in the Absence of Msh2. Immunity. 19(4). 515–524. 50 indexed citations
9.
Luby, Thomas M., Carol E. Schrader, Janet Stavnezer, & Erik Selsing. (2001). The μ Switch Region Tandem Repeats Are Important, but Not Required, for Antibody Class Switch Recombination. The Journal of Experimental Medicine. 193(2). 159–168. 77 indexed citations
10.
Luby, Thomas M., et al.. (2001). Sequences associated with the mouse Sμ switch region are important for immunoglobulin heavy chain transgene expression in B cell development. European Journal of Immunology. 31(10). 2866–2875. 3 indexed citations
11.
Rogers, Bruce L., Julian F. Bond, Jay P. Morgenstern, et al.. (1994). Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes. Molecular Immunology. 31(13). 955–966. 27 indexed citations
12.
Miller, Richard A., Kevin Flurkey, Michael J. Molloy, Thomas M. Luby, & Miguel J. Stadecker. (1991). Differential sensitivity of virgin and memory T lymphocytes to calcium ionophores suggests a buoyant density separation method and a model for memory cell hyporesponsiveness to Con A. The Journal of Immunology. 147(9). 3080–3086. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026